Retatrutide (GLP-RT) Research Peptide – 20 mg

Retatrutide, identified in our catalog as GLP-RT, is a synthetic multi-receptor research peptide supplied in a 20 mg vial for controlled laboratory, analytical, and scientific investigations.

Retatrutide is characterized as a triple-receptor agonist with activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Its simultaneous activity across these three receptor systems has made Retatrutide an important compound for research involving incretin signaling, receptor interactions, metabolic pathways, and related biochemical mechanisms.

The 20 mg format provides researchers with a larger quantity of material per vial, making it suitable for appropriately designed projects requiring multiple analytical procedures, comparative experiments, or larger quantities of research material.

This product is supplied exclusively for laboratory research and analytical purposes. It is not intended for human consumption, veterinary administration, diagnosis, or medical treatment.

Product Specifications

• Full compound name: Retatrutide
• Catalog identifier: GLP-RT
• Strength: 20 mg per vial
• Compound category: Multi-receptor incretin research peptide
• Receptor profile: GLP-1, GIP, and glucagon receptors
• Documentation: Certificate of Analysis available
• Available quantities: 1, 3, 5, 10, or 20 vials
• Shipping origin: United States
• Delivery: Domestic US-to-US shipping
• Intended purpose: Laboratory research and analytical testing only

Retatrutide Research Characteristics

Retatrutide is distinguished by its activity across three receptor systems rather than targeting only a single incretin-related pathway.

The compound is studied for agonist activity at:

GLP-1 Receptors (GLP-1R): A receptor system extensively investigated in metabolic and incretin-signaling research.

GIP Receptors (GIPR): Another incretin-related receptor pathway involved in metabolic signaling investigations.

Glucagon Receptors (GCGR): A receptor pathway studied in connection with metabolic regulation, energy signaling, and related biochemical processes.

The combination of these three activities makes Retatrutide particularly relevant to comparative studies involving single-, dual-, and triple-receptor research compounds.

Potential Research Applications

Retatrutide may be of interest in appropriately designed laboratory studies involving:

• GLP-1 receptor signaling
• GIP receptor signaling
• Glucagon receptor signaling
• Triple-receptor agonism
• Multi-receptor interaction studies
• Incretin-related biochemical pathways
• Metabolic signaling research
• Receptor-binding investigations
• Peptide-receptor interaction studies
• Comparative peptide analysis
• Compound characterization
• Analytical testing
• Stability and degradation studies
• Research method development

References to these pathways describe areas of scientific investigation only and should not be interpreted as therapeutic, medical, weight-management, or personal-use claims for this research material.

Why Choose the 20 mg Research Format?

The 20 mg vial contains twice the amount of research material found in the corresponding 10 mg GLP-RT product.

A higher-content vial may be useful for laboratory projects that require:

• Larger quantities of research material
• Multiple analytical samples
• Replicate experiments
• Comparative testing
• Extended research projects
• Multiple analytical procedures from the same batch

Researchers should select vial quantities according to the requirements of their validated experimental protocols.

COA-Confirmed Research Material

Retatrutide (GLP-RT) Research Peptide – 20 mg is supplied with access to batch-specific Certificate of Analysis (COA) documentation.

Depending on the analytical testing performed for the applicable batch, documentation may include:

• Compound identity
• Batch or lot number
• Tested purity
• Analytical testing methodology
• Laboratory test date
• Reported analytical results

Researchers should review the applicable Certificate of Analysis before beginning an experiment.

The batch-specific COA should always be considered the controlling source for the exact specifications and analytical results associated with an individual lot.

Available Multi-Vial Options

Retatrutide GLP-RT 20 mg is available in multiple quantities to accommodate individual experiments and larger laboratory requirements:

• 1 Vial – Regular Price
• 3 Vials – 5% OFF
• 5 Vials – 10% OFF ★ Most Popular ★
• 10 Vials – 15% OFF
• 20 Vials – 20% OFF

Each vial contains 20 mg of Retatrutide research peptide.

Multi-vial packages provide a lower effective price per vial and may be appropriate for research programs requiring multiple samples, repeat analytical testing, or larger quantities of material from the same product specification.

Storage and Laboratory Handling

Store Retatrutide according to the conditions specified on the product label, packaging, and applicable batch documentation.

General laboratory handling precautions include:

• Keep the vial securely sealed until required
• Protect the material from excessive heat and direct light
• Avoid unnecessary temperature fluctuations
• Protect the material from moisture and contamination
• Use clean laboratory equipment and appropriate handling procedures
• Maintain accurate batch and lot records
• Record storage conditions and handling history
• Follow batch-specific storage requirements
• Minimize unnecessary handling of the research material

Exact storage requirements should always be confirmed using the product label and documentation supplied with the applicable batch.

Laboratory Use and Research Responsibility

Retatrutide GLP-RT 20 mg should be handled by qualified individuals familiar with laboratory procedures and research peptide management.

The purchaser is responsible for ensuring appropriate acquisition, storage, handling, documentation, experimental use, and disposal in accordance with applicable regulations and institutional requirements.

BuyGenerics does not provide personal administration instructions, dosage recommendations, clinical treatment protocols, or therapeutic guidance for this research product.

Domestic US Shipping

Retatrutide (GLP-RT) Research Peptide – 20 mg is available with domestic US-to-US fulfillment.

Ordering benefits include:

• Fast domestic delivery
• No international customs processing
• Discreet packaging
• Secure online ordering
• Tracked shipping options
• Multiple vial quantities
• Quantity discounts of up to 20%

Shipping availability and delivery times may vary depending on destination, inventory availability, order size, and selected delivery service.

Frequently Asked Questions

How much Retatrutide is contained in each vial?

Each vial contains 20 mg of Retatrutide (GLP-RT) research peptide.

What does GLP-RT mean?

GLP-RT is the catalog identifier used for Retatrutide within this research product range.

What receptors are associated with Retatrutide research?

Retatrutide is studied as a triple-receptor agonist with activity at the GLP-1, GIP, and glucagon receptors.

What is the difference between the 10 mg and 20 mg versions?

The compound is the same research material, while the stated quantity per vial differs. The 20 mg version contains twice the nominal amount of research material per vial compared with the 10 mg product.

Is a Certificate of Analysis available?

Yes. Batch-specific Certificate of Analysis documentation is available. Researchers should review the applicable COA for exact analytical specifications and reported test results.

Can I purchase multiple vials?

Yes. Available package quantities include 1, 3, 5, 10, and 20 vials, with increasing quantity discounts.

Does BuyGenerics ship domestically within the United States?

Yes. This product is offered with domestic US-to-US fulfillment, subject to inventory availability and destination.

Is Retatrutide GLP-RT 20 mg intended for human use?

No. This product is sold exclusively for laboratory research and analytical applications and is not intended for human consumption or administration.

Research-Use Disclaimer

Retatrutide (GLP-RT) Research Peptide – 20 mg is intended exclusively for laboratory research, analytical testing, and scientific investigation.

This product is:

• Not for human consumption
• Not for human administration
• Not for veterinary use
• Not a dietary supplement
• Not supplied as a prescription medication
• Not intended to diagnose, treat, cure, or prevent disease
• Not intended for household or recreational use

Information presented on this product page is provided solely for product identification and research-catalog purposes. It does not constitute medical advice, prescribing information, dosage guidance, or instructions for administration.